Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | REGN | GSK | ARGX | ||
| Company | Regeneron Pharmaceuticals | Gsk Plc ADR | Argenx Se ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 726.69 | 51.94 | 872.36 | ||
| High | 764.75 | 51.97 | 873.08 | ||
| Low | 724.79 | 51.38 | 846.16 | ||
| Last | 762.63 | 51.69 | 853.82 | ||
| Change | +24.29 | -0.38 | -18.76 | ||
| Percent Change | +3.29% | -0.73% | -2.15% | ||
| Volume | 1,158,500 | 3,982,100 | 294,600 | ||
| 20-Day Average Volume | 785,480 | 4,603,485 | 290,220 | ||
| Previous | 738.34 | 52.07 | 872.58 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 676.29 | 52.00 | 882.09 | ||
| 20-Day Raw Stochastic | 98.33% | 30.53% | 10.59% | ||
| 20-Day Relative Strength | 71.84 | 48.97 | 47.18 | ||
| Weighted Alpha | +33.00 | +27.62 | +21.63 | ||
| Today's Opinion | 8% Buy | 8% Buy | 56% Buy | ||
| Yesterday's Opinion | 8% Buy | 8% Buy | 72% Buy | ||
| Last Month's Opinion | 72% Sell | 8% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +16.25% since 07/24/26 | +0.66% since 07/24/26 | -7.01% since 07/24/26 | ||
| Low | 659.53 on 07/27/26 | 51.38 on 07/31/26 | 846.16 on 07/31/26 | ||
| High | 764.75 on 07/31/26 | 55.78 on 07/28/26 | 919.16 on 07/27/26 | ||
| 1-Month | |||||
| %Chg | +22.31% since 06/30/26 | -1.39% since 06/30/26 | -7.97% since 06/30/26 | ||
| Low | 623.89 on 07/01/26 | 49.89 on 07/23/26 | 843.59 on 07/17/26 | ||
| High | 764.75 on 07/31/26 | 55.78 on 07/28/26 | 953.58 on 07/02/26 | ||
| 3-Month | |||||
| %Chg | +7.86% since 04/30/26 | -1.19% since 04/30/26 | +9.22% since 04/30/26 | ||
| Low | 591.52 on 06/02/26 | 48.57 on 06/02/26 | 775.02 on 05/01/26 | ||
| High | 764.75 on 07/31/26 | 55.78 on 07/28/26 | 953.58 on 07/02/26 | ||
| 6-Month | |||||
| %Chg | +2.86% since 01/30/26 | +0.17% since 01/30/26 | +1.58% since 01/30/26 | ||
| Low | 591.52 on 06/02/26 | 48.57 on 06/02/26 | 661.85 on 03/20/26 | ||
| High | 815.00 on 02/17/26 | 61.69 on 02/18/26 | 953.58 on 07/02/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 80,625,248 | 104,553,264 | 53,415,836 | ||
| Shares Outstanding, K | 105,720 | 2,022,698 | 62,561 | ||
| Annual Sales, $M | 14,342,900,000 | 43,077,970,000 | 4,248,050,000 | ||
| Annual Net Income, $M | 4,504,900,000 | 7,537,690,000 | 1,292,040,000 | ||
| Last Qtr Sales, $M | 3,605,400,000 | 10,280,080,000 | 1,542,000,000 | ||
| Last Qtr Income, $M | 727,200,000 | 2,340,610,000 | 472,000,000 | ||
| 60-Month Beta | 0.24 | 0.35 | 0.45 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 14.29 on 07/30/26 | 1.36 on 07/28/26 | 7.32 on 07/23/26 | ||
| Latest Earnings Date | 10/27/26 | 11/04/26 | 10/29/26 | ||
| Most Recent Dividend | 0.940 on 05/20/26 | 0.447 on 05/15/26 | N/A | ||
| Next Ex-Dividend Date | 08/18/26 | 08/14/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 18.95 | 10.94 | 33.51 | ||